Sung Lee, EVP & CFO at Sangamo Therapeutics, holds 63.22K shares in Cytokinetics (Ticker: CYTK), holds 22.30K shares in Tango Therapeutics (Ticker: TNGX), holds 100.49K shares in Vir Biotechnology (Ticker: VIR). Most recently, Sung Lee Sold ― shares of Cytokinetics on May 05, 2026 for an estimated value of $1.84M.
What is the percentage of profitable transactions made by Sung Lee?
The percentage of profitable transactions made by Sung Lee is 50%.
What is the average return per transaction made by Sung Lee?
The average return per transaction made by Sung Lee is 16.00%.
What stocks does Sung Lee hold?
Sung Lee holds: SGMO, VIR, CYTK, TNGX stocks.
What was Sung Lee’s latest transaction?
Sung Lee latest transaction was an Informative Sell of $1.84M.
What was Sung Lee's most profitable transaction?
Sung Lee’s most profitable transaction was an Informative Sell of VIR stock on March 28, 2024. The return on the trade was 33.80%.
What is Sung Lee's role in Sangamo Therapeutics?
Sung Lee's role in Sangamo Therapeutics is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.